117 related articles for article (PubMed ID: 11813323)
1. Psammoma bodies in cervicovaginal smears: incidence and significance.
Parkash V; Chacho MS
Diagn Cytopathol; 2002 Feb; 26(2):81-6. PubMed ID: 11813323
[TBL] [Abstract][Full Text] [Related]
2. Psammoma bodies in cervicovaginal smears.
Zreik TG; Rutherford TJ
Obstet Gynecol; 2001 May; 97(5 Pt 1):693-5. PubMed ID: 11339917
[TBL] [Abstract][Full Text] [Related]
3. Psammoma bodies in cervicovaginal smears: significance and practical implications for diagnostic cytopathology.
Fadare O; Chacho MS; Parkash V
Adv Anat Pathol; 2004 Sep; 11(5):250-61. PubMed ID: 15322491
[TBL] [Abstract][Full Text] [Related]
4. Psammoma bodies in cervicovaginal cytology specimens: a clinicopathological analysis of 31 cases.
Misdraji J; Vaidya A; Tambouret RH; Duska L; Bell DA
Gynecol Oncol; 2006 Oct; 103(1):238-46. PubMed ID: 16624389
[TBL] [Abstract][Full Text] [Related]
5. The significance of psammoma bodies in screening cervical cytologic smears.
Muntz HG; Goff BA; McGonigle K; Isacson C
Am J Obstet Gynecol; 2003 Jun; 188(6):1609-12; discussion 1612-4. PubMed ID: 12825000
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of psammoma bodies in Papanicolaou-stained cervicovaginal smears.
Kern SB
Acta Cytol; 1991; 35(1):81-8. PubMed ID: 1994642
[TBL] [Abstract][Full Text] [Related]
7. Psammoma bodies in Papanicolaou tests and associated factors to predict an underlying malignancy: a clinicopathological analysis of 10 cases.
Ersoy E; Kashikar RM
J Am Soc Cytopathol; 2020; 9(4):266-271. PubMed ID: 32376242
[TBL] [Abstract][Full Text] [Related]
8. Psammoma bodies in cervical smears: sifting the grains of sand.
Smith JH
Cytopathology; 2007 Jun; 18(3):140-2. PubMed ID: 17573763
[No Abstract] [Full Text] [Related]
9. Psammoma bodies found in cervicovaginal and/or endometrial smears.
Fujimoto I; Masubuchi S; Miwa H; Fukuda K; Yamaguchi S; Masubuchi K
Acta Cytol; 1982; 26(3):317-22. PubMed ID: 6954813
[TBL] [Abstract][Full Text] [Related]
10. The significance of psammoma bodies on cervical cytology smears.
Nicklin JL; Perrin L; Obermair A; McConachie I; Cominos D
Gynecol Oncol; 2001 Oct; 83(1):6-9. PubMed ID: 11585407
[TBL] [Abstract][Full Text] [Related]
11. Papillary tissue fragments in cervicovaginal (Pap) smears: cytomorphologic characteristics and clinicopathologic significance.
Stoll LM; Johnson MW; Ali SZ
Diagn Cytopathol; 2011 Sep; 39(9):657-62. PubMed ID: 20949454
[TBL] [Abstract][Full Text] [Related]
12. Psammoma bodies in cervical smear in association with keratinizing squamous cell carcinoma of cervix: a case report.
Pillai KR; Sujathan K; Mani KS; Jayalal KS; Somanathan T
Diagn Cytopathol; 2009 Jun; 37(6):450-4. PubMed ID: 19217043
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and significance of psammoma bodies in cervicovaginal smears in a cervical cancer screening program with emphasis on a case of primary bilateral ovarian psammocarcinoma.
Pusiol T; Parolari AM; Piscioli I; Morelli L; Del Nonno F; Licci S
Cytojournal; 2008 Apr; 5():7. PubMed ID: 18416848
[TBL] [Abstract][Full Text] [Related]
14. Ovarian carcinoma identified by psammoma bodies in the cervicovaginal and endometrial smears.
Qizilbash AH
Can Med Assoc J; 1974 Jan; 110(2):185-6. PubMed ID: 4810189
[TBL] [Abstract][Full Text] [Related]
15. Endosalpingiosis as a source of psammoma bodies in a Papanicolaou smear. A case report.
Hallman KB; Nahhas WA; Connelly PJ
J Reprod Med; 1991 Sep; 36(9):675-8. PubMed ID: 1774734
[TBL] [Abstract][Full Text] [Related]
16. Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: diagnostic pitfalls and clues to improve recognition of tumor origin.
Bagby C; Ronnett BM; Yemelyanova A; Maleki Z; Kuhn E; Vang R
Int J Gynecol Pathol; 2013 Sep; 32(5):433-43. PubMed ID: 23896706
[TBL] [Abstract][Full Text] [Related]
17. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population.
Chin AB; Bristow RE; Korst LM; Walts A; Lagasse LD
Am J Obstet Gynecol; 2000 Jun; 182(6):1278-82. PubMed ID: 10871439
[TBL] [Abstract][Full Text] [Related]
18. Cervicovaginal psammoma bodies. The initial presentation of the ovarian borderline tumor.
Qazi FM; Geisinger KR; Barrett RJ; Hopkins MB; Holleman IL
Arch Pathol Lab Med; 1988 May; 112(5):564-6. PubMed ID: 3358659
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of atypical glandular cells of undetermined significance, favor endometrial origin.
Chhieng DC; Elgert P; Cohen JM; Cangiarella JF
Cancer; 2001 Dec; 93(6):351-6. PubMed ID: 11748574
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting pathologic significance among women with atypical glandular cells on liquid-based cytology.
Chatchotikawong U; Ruengkhachorn I; Laiwejpithaya S
Int J Gynaecol Obstet; 2012 Oct; 119(1):30-4. PubMed ID: 22824182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
